Examples of 'co-crystals' in a sentence
Meaning of "co-crystals"
Co-crystals are solid-phase compounds formed by the combination of two or more different molecules or ions through non-covalent interactions. They exhibit unique properties different from their individual components and have applications in various fields, including pharmaceuticals and materials science
How to use "co-crystals" in a sentence
Basic
Advanced
co-crystals
Pharmaceutical compositions of co-crystals of tramadol and coxibs.
The solvent is evaporated to yield the co-crystals.
Co-crystals of the above compounds are also disclosed herein.
All attempts to reproduce said co-crystals failed.
The co-crystals thus obtained have a specific stoichiometry.
This objective was achieved by providing new co-crystals of tramadol.
Co-crystals and pharmaceutical compositions comprising the same.
Agomelatine formulations comprising agomelatine in the form of co-crystals.
Agomelatine co-crystals can exhibit polymorphism.
Crystalline forms of this type are referred to herein as co-crystals.
Co-crystals may be made with multiple triglyceride in a similar manner.
Emulsions also allow the possibility of simultaneous seeding of co-crystals.
These co-crystals are present in the pharmaceutical compositions of the invention.
Emulsions also facilitate the possibility of simultaneous seeding of co-crystals.
Co-crystals produced by any of the methods above are isolated or purified.
See also
The solvent is evaporated to yield the co-crystals of pyrimthanil and dithianon.
Agomelatine co-crystals form unique crystalline structures having unique properties.
Agomelatine in the form of agomelatine co-crystals with organic acids and.
In co-crystals two different solid molecules are crystalliced in a same crystall lattice.
The present invention also includes co-crystals within its scope.
In co-crystals these synthons further pack in the crystalline lattice to form a molecular crystal.
In a specific embodiment, the co-crystals of the present invention contain adipic acid.
It was succeeded to crystallise itraconazole malonic acid co-crystals with used methods.
In another embodiment, the co-crystals are washed after filtration to remove excess triglyceride.
Such wetting agents can also be useful in solubilizing or increasing the solubility of co-crystals.
Suitable preparation methods for the co-crystals of pyrimethanil and dithianon are as follows.
These co-crystals can be used in medicaments for the treatment of epilepsy or trigeminal neuralgia.
Hence the invention further provides co-crystals comprising a compound of the invention.
These co-crystals may be prepared from compounds of the invention by known co-crystal forming procedures.
Methods for making and characterizing co-crystals are known to those of skill in the art.
The co-crystals may however, include one or more solvate molecules in the crystalline lattice.
Methods for making and characterizing co-crystals are well to those of skill in the art.
Co-crystals may also be formed from a salt of the compound and an additional molecular species.
This object has been achieved by the co-crystals of pyrimethanil and dithianon as described below.
These methods in general are also suitable for preparing and characterizing co-crystals of this invention.
Additionally, the compositions and co-crystals of this invention can be used as research tools.
The crystalline forms according to the invention may optionally also form co-crystals and / or clathrates.
Crude co-crystals were isolated by centrifugal filtration using Millipore 2ml centrifugation devices.
The compound of the invention may be capable of forming co-crystals with suitable co-crystal formers.
Co-crystals contain an API and at least one other component which crystallize together.
The compounds of the present invention may be prepared as co-crystals using any suitable method.
Co-crystals of Agomelatine are crystalline structures composed of Agomelatine and at least one other component.
Hence the invention further provides co-crystals comprising a compound of formula III.
The co-crystals thus obtained have a specific stoichiometry which depends upon the structure of each NSAID.
Preparation method I for the preparation of a stable composition of co-crystals of pyrimethanil and dithianon,.
More preferably, co-crystals of AIF polypeptide and AIF binding partner can be studied.
It was found that Tramadol was able to form Co-crystals with NSAIDs.
Preferred co-crystals include p-toluenesulfonic acid and benzenesulfonic acid.
The 1H NMR results are consistent with high performance liquid chromatography analysis of the co-crystals.
Hence the invention further provides co-crystals comprising a compound of formula I or I '.
